Concepedia

Effie Pournara

EP

18

Publications

712

Citations

14

H-Index

2016

Active since

Affiliations

Novartis (Switzerland)(Current)

Rheumazentrum Ruhrgebiet

Ruhr University Bochum

University of Oxford

Novartis (Germany)

Effie Pournara is an author at Novartis (Switzerland) specializing in medicine, pediatric endocrinology, and nutrition development.

Top concepts

Publications per year

2016–2023

18

Publications

18

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

Xenofon Baraliakos, Laure Gossec, Effie Pournara et al. · Annals of the Rheumatic Diseases · 2020 · 178 citations · Full text

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

Nils Venhoff, Wolfgang Schmidt, Raoul Bergner et al. · The Lancet Rheumatology · 2023 · 74 citations

, , +6

Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet® International Outcome Study

Michel Polak, Joanne Blair, Primož Kotnik et al. · European Journal of Endocrinology · 2017 · 63 citations · Full text

Short Stature: Comparison of WHO and National Growth Standards/References for Height

Henrik Thybo Christesen, Effie Pournara, Isabelle Petit et al. · PLoS ONE · 2016 · 60 citations · Full text

, , +24

Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label <scp>OPTIMISE</scp> study

Kristian Reich, L. Puig, Jacek C. Szepietowski et al. · British Journal of Dermatology · 2019 · 60 citations

Rows per page

1–5 of 18